Brief: Qiagen Gets FDA Clearance Of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
08/01/2024 07:10
Jan 8 (Reuters) - QIAGEN NV QIA.DE :
* QIAGEN RECEIVES FDA CLEARANCE OF NEUMODX CT/NG ASSAY FOR
USE ON
BOTH NEUMODX 96 AND 288 MOLECULAR SYSTEMS
Source text for Eikon: ID:nGNX6Swy9M
Further company coverage: QIA.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))